Celgene Corporation

59 Presentations and Posters Evaluating Celgene Products to Be Highlighted at the 45th American Society of Clinical Oncology Meeting

Published in Healthcare Finance, Tax and Law Weekly, June 10th, 2009

Celgene Corporation (NASDAQ: CELG) announced that clinical investigators from leading cancer research centers will present data from recent and on-going clinical trials of multiple Celgene products in blood cancers and solid tumors at the 45th American Society of Clinical Oncology (ASCO) Meeting in Orlando, Florida from May 29 – June 2, 2009.

For more information and for complete abstracts, please visit http://www.abstract.asco.org/.

Keywords: , Health, Oncology, Pharmaceutical, Other Health, Biotechnology Business, Biotechnology Company, Blood Cancer, Blood Carcinoma, Cancer Research, Celgene Corporation, Clinical Oncology, Clinical Trial Research,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly

Source: Healthcare Finance, Tax and Law Weekly (2009-06-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry